Real-time enrollment status for this paroxysmal nocturnal hemoglobinuria (pnh) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:47 AM UTC
| NCT Number | NCT06934967 |
| Recruiting Status | Recruiting |
| Condition | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Phase | PHASE3 |
| Target Enrollment | 12 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 18, 2026: Clinical trial NCT06934967 is currently recruiting participants. This phase3 study for paroxysmal nocturnal hemoglobinuria (pnh) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06934967 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06934967 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.